首页> 外文OA文献 >Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013

【2h】

Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013

机译：非何杰金淋巴瘤同种异体干细胞移植后的结果：德克萨斯州儿童医院的经验1999-2013年。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Naik Swati; Castillo Paul; Martinez Caridad; Leung Kathryn; Sasa Ghadir; Gottschalk Stephen; Ahmed Nabil M.; Allen Carl; Krance Robert A.; Brenner Malcolm K.; Heslop Helen E.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 20:52:01

相似文献

外文文献
中文文献
专利

1. Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013 [J] . Naik Swati, Castillo Paul, Martinez Caridad, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：非何杰金淋巴瘤同种异体干细胞移植后的结果：德克萨斯州儿童医院的经验1999-2013年。
2. Pretransplantation (18-F)fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation. [J] . Dodero A, Crocchiolo R, Patriarca F, Cancer: A Journal of the American Cancer Society . 2010,第21期

机译：移植前（18-F）氟脱氧葡萄糖正电子发射断层扫描可以预测复发性霍奇金淋巴瘤或侵袭性非霍奇金淋巴瘤患者的强度降低，然后再进行同种异体干细胞移植。
3. Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation [J] . Anna Dodero MD, Roberto Crocchiolo MD, Francesca Patriarca MD, Cancer . 2010,第21期

机译：移植前[18-F]氟脱氧葡萄糖正电子发射断层扫描可以预测复发性霍奇金淋巴瘤或侵袭性非霍奇金淋巴瘤患者的强度降低条件，然后进行同种异体干细胞移植
4. SmartTransplantation - Allogeneic Stem Cell Transplantation as a Model for a Medical Expert System [C] . Gerrit Meixner, Nancy Thiels, Ulrike Klein Symposium of the Workshop on Human-Computer Interaction and Usability Engineering of the Austrian Computer Society(USAB 2007); 20071122; Graz(AT) . 2007

机译：SmartTransplantation-同种异体干细胞移植作为医学专家系统的模型
5. Children with acute leukemia: A comparison of outcomes and cost-effectiveness from allogeneic blood stem cell and bone marrow transplantation. [D] . Lin, Yu-Feng. 2009

机译：儿童急性白血病：同种异体造血干细胞和骨髓移植的疗效和成本效益比较。
6. Correlation of Pretransplant and Early Post-Transplant Response Assessment With Outcomes After Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma [O] . Michael R. Bishop, Robert M. Dean, Seth M. Steinberg, -1

机译：对术后非霍奇金淋巴瘤减少的异种造血干细胞移植术后预防蛋白及早期移植后响应评估的相关性
7. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-Cell Non-Hodgkin’s lymphoma1,2 1Expert panel members and authors of the review are: Theresa Hahn, PhD, Roswell Park Cancer Institute, Buffalo, NY; Steven N. Wolff, MD, Vanderbilt University, Nashville, TN, Myron Czuczman, MD, Roswell Park Cancer Institute, Buffalo, NY; Richard I. Fisher, MD, Cardinal Bernardin Cancer Center, Loyola University, Chicago, IL; Hillard M. Lazarus, MD, Comprehensive Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH; Philip L. McCarthy, MD, Roswell Park Cancer Institute, Buffalo, NY; Julie Vose, MD, University of Nebraska Medical Center, Omaha, NE; Lisa Warren, Cure for Lymphoma Foundation, New York, NY; and Richard Watt, MD, United Resource Networks, Minneapolis, MN. 2Reference: Hahn T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence-based review. Biol Blood Marrow Transplant. 2001;7:308–331. [O] . 2003

机译：造血干细胞移植的细胞毒性治疗在治疗弥漫性大细胞B细胞非霍奇金淋巴瘤1,2中的作用1，专家小组成员和评价的作者是：纽约州布法罗罗斯威尔公园癌症研究所的特蕾莎·哈恩博士；田纳西州纳什维尔范德比尔特大学医学博士斯蒂芬·沃尔夫（Steven N. Wolff），纽约州布法罗罗斯维尔公园癌症研究所医学博士迈伦·库兹曼（Myron Czuczman）；理查德·费舍尔（Richard I. Fisher）医学博士，伊利诺伊州芝加哥洛约拉大学贝纳尔丁枢机主教癌症中心；俄亥俄州克利夫兰凯斯西储大学克利夫兰大学医院综合癌症中心医学博士Hillard M. Lazarus；纽约州布法罗罗斯韦尔公园癌症研究所医学博士Philip L.内布拉斯加州奥马哈市内布拉斯加大学医学中心医学博士Julie Vose；丽莎·沃伦（Lisa Warren），纽约州纽约市淋巴瘤基金会的治疗；和明尼苏达州明尼阿波利斯市联合资源网络公司的医学博士Richard Watt。 2参考文献：Hahn T，Wolff SN，Czuczman M等。一项基于证据的综述：造血干细胞移植的细胞毒性治疗在弥漫性大细胞B细胞非霍奇金淋巴瘤治疗中的作用。 Biol骨髓移植。 2001; 7：308-331。

Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013

著录项

相似文献

相关主题

期刊订阅